GoodRx (GDRX) downgraded due to falling users and policy risks. Learn about new revenue sources and competitive threats.

What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) fell 1.7% in the afternoon session after Barclays initiated coverage on the health-focused technology company with an "Underweight ...

Pharmacy benefit manager MedImpact is teaming up with GoodRx on a new program that offers drug discounts "seamlessly" at the pharmacy counter. Under the initiative, when a MedImpact member gets a ...

Morgan Stanley lowered the firm’s price target on GoodRx (GDRX) to $4 from $5 and keeps an Equal Weight rating on the shares. For healthcare ...

The GoodRx for Weight Loss telemedicine subscription is available for an introductory rate of $39 per month through January 2026, with a standard price of $119 beginning on February 1, 2026.

CANADA - 2025/03/06: In this photo illustration, the GoodRx Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) Free ...

A live webcast will be available on the Company's Investor Relations website, https://investors.goodrx.com/. Following the conference, an archived recording will be available on the Company’s website ...

Choose Providence Business First as a preferred news source to see more of our reporting on Google. The class action claims ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

GoodRx is leveraging partnerships with Novo Nordisk and potential TrumpRx involvement to offset stagnating user growth and drive higher-margin revenue. Despite a 14% decline in Monthly Active ...

A few weeks ago, a Philadelphia resident named Marie received a prescription for a new medication, but the drug wasn’t covered by her insurance. “It was way too expensive for me to get on my own,” she ...